PCV/mycoplasma hyopneumoniae vaccine
US11154609B2 · kind B2 · utility
0Cited by
59References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 28, 2020 |
| Grant date | Oct 26, 2021 |
| Priority date | — |
| Expiry date | Apr 28, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2750/10034
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides a combination vaccine which includes a porcine circovirus type 2 (PCV2) antigen and a cell free Mycoplasma hyopneumoniae (M. hyo) culture supernatant for protecting a pig against PCV2 and M. hyo infections, wherein the M. hyo culture supernatant is substantially free of PCV2 antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.